Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Supportive Care in Cancer
Metadata
Title
Prevalence and risk factors for insomnia among breast cancer patients on aromatase inhibitors
Publication date
01-01-2013
Published in
Supportive Care in Cancer / Issue 1/2013
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-012-1490-z

Other articles of this Issue 1/2013

Supportive Care in Cancer 1/2013 Go to the issue

Special Article

Systematic review of oral cryotherapy for management of oral mucositis caused by cancer therapy

Original Article

How does the Distress Thermometer compare to the Hospital Anxiety and Depression Scale for detecting possible cases of psychological morbidity among cancer survivors?

Original Article

A cross-sectional study of constipation and laxative use in advanced cancer patients: insights for revision of current practice

Original Article

The impact of chemotherapy-related nausea on patients' nutritional status, psychological distress and quality of life

Original Article

Laxative prescriptions to cancer outpatients receiving opioids: a study from the Norwegian prescription database

Original Article

Surrogate decision-making in Korean patients with advanced cancer: a longitudinal study
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits